Mirtazapine

CHEMBL654 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
265.4 g/mol
LogP
3.3
Phase
4

This antidepressant works by blocking specific receptors in the brain to increase levels of serotonin and norepinephrine, improving mood and promoting sleep. It is often chosen when sedation and appetite stimulation are desired alongside antidepressant effects.

Molekularmasse

265,3500 g/mol

LogP

3,30

TPSA

19,40 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN1CCN2c3ncccc3Cc3ccccc3C2C1

InChI

InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3

Molecular Formula

C17H19N3

HBD / HBA

- / 3

Rotierbare Bindungen

0

Schwere Atome

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

This antidepressant works by blocking specific receptors in the brain to increase levels of serotonin and norepinephrine, improving mood and promoting sleep. It is often chosen when sedation and appetite stimulation are desired alongside antidepressant effects.

Yes, Mirtazapine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL654. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4205. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.